Clinical trial · Observational
Mortality of Cancer Surgery During SARS CoV2 Pandemic
Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The impact of cancer surgery during covid epidemic is not clear. The published reports show contradictory findings that extend from no change in mortality to increased mortality, further no data on exposure and outcome of health care worker is available. This study is designed to address the above questions
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| SARS CoV 2 Infection | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgery | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Pre covid
- description
- Cases operated one year prior to the date of declaration of corona pandemic in India
- interventionNames
- Other: Surgery
- label
- post covid
- description
- cases operated from the date of declaration of corona pandemic to one year after
- interventionNames
- Other: Surgery
Primary outcomes (2)
- measure
- 30 day mortality
- timeFrame
- 30 days
- description
- post operative deaths within one year
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * All patients operated during the study period Exclusion Criteria: * None
References
Publications (0)
Data not yet available